Lifshitz Law Firm announces investigation of Dynavax and others
Lifshitz first announced that a class action law suit was filed in the United States District Court for the Northern District of California against Dynavax. The class action law suit claims that Dynavax issued false and misleading statements to investors between April 26, 2012 and June 10, 2013.
Lifshitz then announced that it was starting an investigation into Keynote Systems. Keynote allegedly experienced possible breaches of fiduciary duty related to the proposed sale of the company to an affiliate of Thoma Bravo, LLC. The all-cash transaction was estimated to be valued at a $395 million or $20.00 per share.
Lifshitz also announced that it has started an investigation into sTec. The investigation looks into alleged breaches of fiduciary duty in connection with the proposed sale of sTec to Western Digital Corporation. The transaction is valued to be at approximately $340 million or around $6.85 per share.
Finally, Lifshitz announced an investigation into Vanguard Health Systems regarding alleged breaches of fiduciary duty in connection with the proposed sale of Vanguard to Tenet Healthcare Corporation. This transaction is valued at around $4.3 billion, including the assumption of $2.5 billion in Vanguard debt.